BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37491664)

  • 1. A time-dependent Poisson-Gamma model for recruitment forecasting in multicenter studies.
    Turchetta A; Savy N; Stephens DA; Moodie EEM; Klein MB
    Stat Med; 2023 Oct; 42(23):4193-4206. PubMed ID: 37491664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The time-dependent Poisson-gamma model in practice: Recruitment forecasting in HIV trials.
    Turchetta A; Moodie EEM; Stephens DA; Savy N; Moodie Z
    Contemp Clin Trials; 2024 Jun; ():107607. PubMed ID: 38908745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian modeling and prediction of accrual in multi-regional clinical trials.
    Deng Y; Zhang X; Long Q
    Stat Methods Med Res; 2017 Apr; 26(2):752-765. PubMed ID: 25367100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Bayesian methods for flexible modeling of spatial risk surfaces in disease mapping.
    Sturtz S; Ickstadt K
    Biom J; 2014 Jan; 56(1):5-22. PubMed ID: 24130078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does Poisson kriging compare to the popular BYM model for mapping disease risks?
    Goovaerts P; Gebreab S
    Int J Health Geogr; 2008 Feb; 7():6. PubMed ID: 18248676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustifying Bayesian nonparametric mixtures for count data.
    Canale A; Prünster I
    Biometrics; 2017 Mar; 73(1):174-184. PubMed ID: 27124115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim recruitment prediction for multi-center clinical trials.
    Urbas S; Sherlock C; Metcalfe P
    Biostatistics; 2022 Apr; 23(2):485-506. PubMed ID: 32978616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Poisson-gamma model to evaluate the duration of recruitment process when historical trials are available.
    Minois N; Lauwers-Cances V; Savy S; Attal M; Andrieu S; Anisimov V; Savy N
    Stat Med; 2017 Oct; 36(23):3605-3620. PubMed ID: 28608361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling time-varying recruitment rates in multicenter clinical trials.
    Perperoglou A; Zhang Y; Kipourou DK
    Biom J; 2023 Aug; 65(6):e2100377. PubMed ID: 36287068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zero-modified Poisson model: Bayesian approach, influence diagnostics, and an application to a Brazilian leptospirosis notification data.
    Conceição KS; Andrade MG; Louzada F
    Biom J; 2013 Sep; 55(5):661-78. PubMed ID: 23564691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some issues in predicting patient recruitment in multi-centre clinical trials.
    Bakhshi A; Senn S; Phillips A
    Stat Med; 2013 Dec; 32(30):5458-68. PubMed ID: 24105891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxed Poisson cure rate models.
    Rodrigues J; Cordeiro GM; Cancho VG; Balakrishnan N
    Biom J; 2016 Mar; 58(2):397-415. PubMed ID: 26686485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian estimation of stimulus responses in Poisson spike trains.
    Lehky SR
    Neural Comput; 2004 Jul; 16(7):1325-43. PubMed ID: 15165392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible Bayesian nonconfounding spatial model for analysis of dispersed count data.
    Nadifar M; Baghishani H; Fallah A
    Biom J; 2022 Apr; 64(4):758-770. PubMed ID: 34985802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian Poisson hierarchical models for crash data analysis: Investigating the impact of model choice on site-specific predictions.
    Khazraee SH; Johnson V; Lord D
    Accid Anal Prev; 2018 Aug; 117():181-195. PubMed ID: 29705601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials.
    Wu J; Chen MH; Schifano ED; Ibrahim JG; Fisher JD
    Stat Med; 2019 Dec; 38(30):5565-5586. PubMed ID: 31691322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian Spatial Joint Model for Disease Mapping of Zero-Inflated Data with R-INLA: A Simulation Study and an Application to Male Breast Cancer in Iran.
    Asmarian N; Ayatollahi SMT; Sharafi Z; Zare N
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31766251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the geometric modeling approach to empirical null distribution estimation for empirical Bayes modeling of multiple hypothesis testing.
    Wu B
    Comput Biol Chem; 2013 Apr; 43():17-22. PubMed ID: 23314152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivariate zero-inflated regression for count data: a Bayesian approach with application to plant counts.
    Majumdar A; Gries C
    Int J Biostat; 2010; 6(1):Article 27. PubMed ID: 21969981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.